RECRUITING Not applicable ClinicalTrials.gov

Tele-Pulmonary Rehabilitation For Patients With Chronic Lung Diseases

Sponsor: Tel-Aviv Sourasky Medical Center • ClinicalTrials.gov ID: NCT07666841

Registry updated: 2026-09-24

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Description

Pulmonary rehabilitation is a key treatment for lung diseases, but many patients struggle to attend sessions due to travel distances, physical limitations, or logistical barriers. The purpose of this study is to evaluate whether a tele-pulmonary rehabilitation (TPR) program can improve the rates of treatment initiation and adherence among patients with chronic lung diseases compared to traditional, center-based pulmonary rehabilitation. Additionally, the study will assess improvements in quality of life, physical symptoms, and safety in both groups. This study will enroll 90 patients from two medical centers in Israel (Tel Aviv and Barzilai). Participants will be randomly assigned to one of two groups: 1. The control group will receive usual care with a referral by a pulmonologist to standard pulmonary rehabilitation at a medical center. 2. The intervention group will participate in a supervised remote tele-rehabilitation program using a dedicated application and remote monitoring.

Interventions

Tele-Rehabilitation (Other)
Participants will undergo a 12 weeks tele-rehabilitation program using a dedicated application. The intervention consists of 24 online sessions (twice weekly) led by a senior respiratory physiotherapist in groups of up to 5 participants. The sessions include: 1. Supervised Exercise: Aerobic and resistance training using household items, stretching, and breathing techniques. 2. Remote Monitoring: Vital signs (heart rate and oxygen saturation) monitored every 10-15 minutes via a study-provided pulse oximeter. 3. Comprehensive Education: Guidance on lifestyle, nutrition, and physical activity. 4. Digital Support: The app provides activity tracking, symptom logging, session reminders, and guided home exercises. At the end of each session, every participant receives a personalized exercise plan based on their performance and preferences, which is displayed in the app.

Eligibility criteria

Inclusion Criteria: 1. Patients meeting the Israeli Health Basket criteria for reimbursement of pulmonary rehabilitation (PR), including one of the following conditions: * COPD with an FEV1 below 50% or with severe exacerbation (hospitalization) in the previous year or two moderate exacerbations in the previous year. * Interstitial lung disease with an FVC below 80% or a DLCO below 60%. * Bronchiectasis with at least two exacerbations in the past year or at least one hospitalization, and an FEV1 below 80%. * Pulmonary arterial hypertension. 2. Willingness to initiate a PR or Tele-PR (TPR) programs. 3. Ability to perform the TPR program or traditional PR activities as assessed by a member of the study team prior to enrollment. 4. Agree to participate, with signed informed consent. Exclusion Criteria: 1. Uncontrolled comorbidity (e.g uncontrolled congestive heart failure) 2. Inability to operate the mobile application. 3. Without a mobile device or computer. 4. A hospitalization in the 2-months prior to randomization. 5. Completed PR program in the last 12 months. 6. Inability to complete 10 repetitions in the 1-minute sit-to-stand test or 5-second single-leg stance 7. Pregnancy 8. Inability to provide informed consent due to impaired decision-making capacity, as determined by the study's capacity assessment.

Conditions

COPD (Chronic Obstructive Pulmonary Disease) Rehabilitation Bronchiectasis Adult Pulmonary Arterial Hypertension (PAH) Interstitial Lung Disease (ILD)

Locations

Barzilai Medical Center — Ashkelon, Israel
Tel Aviv Sourasky Medical Center — Tel Aviv, Israel

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record

Accelerate Your Clinical Trial Recruitment